Signal: Fresh Tracks nears end of operations with plans for dissolution
Fresh Tracks Therapeutics has announced a proposed dissolution and liquidation of the company in “an orderly fashion” as stated by…
All articles by Judith Oke
Judith Oke
Judith Oke is an Editor for the Clinical Trial Arena Network, covering developments across the clinical trials landscape. With a background in Pharmacy, she has edited several peer-reviewed articles for publication in Journals like Elsevier, Springer, BMJ and Frontiers, including but not limited to key areas/topics like infectious diseases, cardiovascular diseases, and obstetrics and gynaecology.
-
-
Signal: Novo Nordisk’s Wegovy enters new borders
Novo Nordisk’s Wegovy has launched in the UK, as announced by the company in a statement on 4 September. As…
-
Signal: Apellis sheds staff weight plus R&D in a bid to restructure company
With the ongoing trend of layoffs amongst pharma companies, Apellis Pharmaceuticals is planning to take a cut on about 225…
-
Signal: Porosome files comprehensive patent for therapies to treat cystic fibrosis and other health conditions
Porosome Therapeutics has announced a potentially novel treatment for cystic fibrosis while stating that it has filed a comprehensive patent…
-
Signal: Tweets of the week focus on Eli Lilly’s most recent acquisitions
Eli Lilly continues to make news by announcing its complete acquisition of the Massachusetts-headquartered Sigilon on 14 August. The deal…
-
Signal: Sensorion Raises $38.37m in Private Placement of Shares
The deal Sensorion announced a private placement financing of €35m ($38.37m) made by its existing shareholders Invus and Sonnova Partners,…
-
Patents signal: Patent authorities in China champion grants awarded to Pharma companies
Each week, Clinical Trials Arena journalists analyse data on patent filings and grants that illustrate innovation trends in our sector.…
-
Deal focus: Fresh Tracks discloses its $8.25m buyout from Botanix
Each week, Clinical Trials Arena editors select a deal that illustrates the themes driving change in our sector. The deal…
-
Filings signal: ARCA’s Q2 2023 reports
Each week, Clinical Trials Arena journalists pick out insights from company filings that highlight sentiments in our sector. These filings…
-
Patents signal: Chinese Academy of Sciences tops assignees for Q2 2023
Each week, Clinical Trials Arena journalists analyse data on patent filings and grants that illustrate innovation trends in our sector.…